Multicenter phase II trial of gefitinib first-line therapy followed by chemotherapy in advanced non-small-cell lung cancer (NSCLC): SAKK protocol 19/03

G. D'Addario; D. Rauch; R. Stupp; M. Pless; R. Stahel; N. Mach; L. Jost; L. Widmer; C. Tapia; M. Bihl; M. Mayer; K. Ribi; S. Lerch; L. Bubendorf; D.C. Betticher

doi:10.1093/annonc/mdm564

Multicenter phase II trial of gefitinib first-line therapy followed by chemotherapy in advanced non-small-cell lung cancer (NSCLC): SAKK protocol 19/03

G. D'Addario
, D. Rauch
, R. Stupp
, M. Pless
, R. Stahel
, N. Mach
, L. Jost
, L. Widmer
, C. Tapia
, M. Bihl
, M. Mayer
, K. Ribi
, S. Lerch
, L. Bubendorf
, D.C. Betticher

Careum School of Health

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	739-745
Journal	Annals of Oncology
Volume	19
Issue number	4
DOIs	https://doi.org/10.1093/annonc/mdm564
Publication status	Published - 1 Apr 2008

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1093/annonc/mdm564Licence: Other

https://linkinghub.elsevier.com/retrieve/pii/S0923753419414580

Cite this

D'Addario, G., Rauch, D., Stupp, R., Pless, M., Stahel, R., Mach, N., Jost, L., Widmer, L., Tapia, C., Bihl, M., Mayer, M., Ribi, K., Lerch, S., Bubendorf, L., & Betticher, D. C. (2008). Multicenter phase II trial of gefitinib first-line therapy followed by chemotherapy in advanced non-small-cell lung cancer (NSCLC): SAKK protocol 19/03. Annals of Oncology, 19(4), 739-745. https://doi.org/10.1093/annonc/mdm564

@article{bf7d5239eefc412ca78e82dc9c241cbb,

title = "Multicenter phase II trial of gefitinib first-line therapy followed by chemotherapy in advanced non-small-cell lung cancer (NSCLC): SAKK protocol 19/03",

author = "G. D'Addario and D. Rauch and R. Stupp and M. Pless and R. Stahel and N. Mach and L. Jost and L. Widmer and C. Tapia and M. Bihl and M. Mayer and K. Ribi and S. Lerch and L. Bubendorf and D.C. Betticher",

year = "2008",

month = apr,

day = "1",

doi = "10.1093/annonc/mdm564",

language = "English",

volume = "19",

pages = "739--745",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Elsevier Ltd.",

number = "4",

}

D'Addario, G, Rauch, D, Stupp, R, Pless, M, Stahel, R, Mach, N, Jost, L, Widmer, L, Tapia, C, Bihl, M, Mayer, M, Ribi, K, Lerch, S, Bubendorf, L & Betticher, DC 2008, 'Multicenter phase II trial of gefitinib first-line therapy followed by chemotherapy in advanced non-small-cell lung cancer (NSCLC): SAKK protocol 19/03', Annals of Oncology, vol. 19, no. 4, pp. 739-745. https://doi.org/10.1093/annonc/mdm564

TY - JOUR

T1 - Multicenter phase II trial of gefitinib first-line therapy followed by chemotherapy in advanced non-small-cell lung cancer (NSCLC): SAKK protocol 19/03

AU - D'Addario, G.

AU - Rauch, D.

AU - Stupp, R.

AU - Pless, M.

AU - Stahel, R.

AU - Mach, N.

AU - Jost, L.

AU - Widmer, L.

AU - Tapia, C.

AU - Bihl, M.

AU - Mayer, M.

AU - Ribi, K.

AU - Lerch, S.

AU - Bubendorf, L.

AU - Betticher, D.C.

PY - 2008/4/1

Y1 - 2008/4/1

U2 - 10.1093/annonc/mdm564

DO - 10.1093/annonc/mdm564

M3 - Article

SN - 0923-7534

VL - 19

SP - 739

EP - 745

JO - Annals of Oncology

JF - Annals of Oncology

IS - 4

ER -